ArticleEuropean journal of nuclear medicine and molecular imaging2010

Switch from antagonist to agonist after addition of a DOTA chelator to a somatostatin analog.

Jean Claude Reubi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.